---
schema_version: "secwatch.filing_event.v1"
accession: "0001193805-23-001486"
form_type: "8-K"
ticker: "IMUX"
cik: "0001280776"
company_name: "IMMUNIC, INC."
filed_at: "2023-11-14T23:59:59+00:00"
generated_at: "2026-06-08T03:14:33.410354+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Immunic reports Q3 2023 net loss $22.8M; positive CALLIPER interim NfL data

## Summary
- Net loss of $22.8M ($0.51/sh) for Q3 2023 vs $21.2M ($0.69/sh) in Q3 2022.
- Cash and investments of $59.7M as of Sep 30, 2023; expected runway into Sep 2024.
- Phase 2 CALLIPER trial in progressive MS met interim biomarker endpoint: serum NfL improved vs placebo across all subtypes.
- Received US patent notice of allowance for vidofludimus calcium in relapsing MS, extending protection to 2041.
- CALLIPER enrollment completed (467 pts); top-line data expected April 2025; ENSURE interim futility late 2024.

## SEC filing metadata
- accession: 0001193805-23-001486
- form_type: 8-K
- ticker: IMUX
- cik: 0001280776
- company_name: IMMUNIC, INC.
- filed_at: 2023-11-14T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1280776/000119380523001486/0001193805-23-001486-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1280776/000119380523001486/e619056_8k-immunic.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193805-23-001486
- JSON: https://secwatch.observer/filing/0001193805-23-001486.json
- Plain text: https://secwatch.observer/filing/0001193805-23-001486.txt

## Key facts
- Earnings Releases
  IMMUNIC, INC. reported financial results for the third quarter ended September 30, 2023.
  - Period: the third quarter ended September 30, 2023
  - Result: reported results
  source text: On November 14, 2023, Immunic, Inc. (the “Company”) issued a press release, a copy of which is furnished herewith as Exhibit 99.1, announcing the Company’s financial results for the quarter ended September 30, 2023 and providing a corporate update
  evidence_url: https://www.sec.gov/Archives/edgar/data/1280776/000119380523001486/0001193805-23-001486-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.